Abstract 1850: Co-targeting EZH2 and TEAD elicits apoptosis through tumor-intrinsic innate immune signaling in Hippo pathway-mutated cancers.
Antja-Voy Hartley, Mustafa Al-Dulaimi, Navin R. Mahadevan, Pinar Eser et autres
0 citationsCancer Research
Antja-Voy Hartley
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
43Publications signalées
495Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Lung Cancer Treatments and MutationsCAR-T cell therapy researchLung Cancer Research StudiesCancer Immunotherapy and BiomarkersCancer-related gene regulation
Publications récentes
Data from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
Simon Baldacci, Elliott J. Brea, Francesco Facchinetti, Zhaorong Li et autres
0 citations
Figure S2 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
Simon Baldacci, Elliott J. Brea, Francesco Facchinetti, Zhaorong Li et autres
0 citations
Figure S11 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
Simon Baldacci, Elliott J. Brea, Francesco Facchinetti, Zhaorong Li et autres
0 citations
Figure S5 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
Simon Baldacci, Elliott J. Brea, Francesco Facchinetti, Zhaorong Li et autres
0 citations
Figure S4 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
Simon Baldacci, Elliott J. Brea, Francesco Facchinetti, Zhaorong Li et autres
0 citations
Figure S1 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
Simon Baldacci, Elliott J. Brea, Francesco Facchinetti, Zhaorong Li et autres
0 citations
Figure S3 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
Simon Baldacci, Elliott J. Brea, Francesco Facchinetti, Zhaorong Li et autres
0 citations
Figure S10 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
Simon Baldacci, Elliott J. Brea, Francesco Facchinetti, Zhaorong Li et autres
0 citations
Figure S6 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
Simon Baldacci, Elliott J. Brea, Francesco Facchinetti, Zhaorong Li et autres
0 citations
Figure S7 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
Simon Baldacci, Elliott J. Brea, Francesco Facchinetti, Zhaorong Li et autres
0 citations
Figure S8 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
Simon Baldacci, Elliott J. Brea, Francesco Facchinetti, Zhaorong Li et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.